BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Dataset: Genomic Grade Index (GGI): Feasibility in routine practice and impact on treatment decisions in early breast cancer

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this...

Registered by ArrayExpress Uploader
View Dataset

Genomic Grade Index (GGI) is a 97-gene signature that improves histologic grade (HG) classification in invasive breast carcinoma. In this prospective study we sought to evaluate the feasibility of performing GGI in routine clinical practice and its impact on treatment recommendations. Patients with pT1pT2 or operable pT3, N0-3 invasive breast carcinoma were recruited from 8 centers in Belgium. Fresh surgical samples were sent at room temperature in the MapQuant Dx™ PathKit for centralized genomic analysis. Genomic profiles were determined using Affymetrix U133 Plus 2.0 and GGI calculated using the MapQuant Dx™ protocol, which defines tumors as low or high Genomic Grade (GG-1 and GG-3 respectively). 180 pts were recruited and 155 were eligible. The MapQuant test was performed in 142 cases and GGI was obtained in 78% of cases (n=111). Reasons for failures were 15 samples with <30% of invasive tumor cells (11%), 15 with insufficient RNA quality (10%), and 1 failed hybridization (<1%). For tumors with an available representative sample (≥ 30% inv. tumor cells) (n=127), the success rate was 87.5 %. GGI reclassified 69% of the 54 HG2 tumors as GG-1 (54%) or GG-3 (46%). Changes in treatment recommendations occurred mainly in the subset of HG2 tumors reclassified into GG-3, with increased use of chemotherapy in this subset. The use of GGI is feasible in routine clinical practice and impacts treatment decisions in early-stage breast cancer. Total RNA was extracted from fresh tumor tissues comprising ≥30% invasive tumor cells and hybridized on Affymetrix microarrays if the RIN was ≥ 7.

Species:
human

Samples:
111

Source:
E-GEOD-43365

Updated:
Dec.12, 2014

Registered:
Jul.12, 2014


Factors: (via ArrayExpress)
Sample PR GG CENTRE COMORB GRADE HISTO AGE HIST MENOP SIZE MM HER2 NODES GGI ER
GSM1061142 1 equivocal 1 average for age 2 80 lobular postmenopausal 15 0 0 -0.3 1
GSM106114 1 equivocal 1 minor 1 75 ductal postmenopausal 10 0 0 0.2 1
GSM1061140 0 3 1 minor 3 42 ductal premenopausal 17 0 0 2 1
GSM1061139 1 1 1 minor 1 51 ductal postmenopausal 11 0 0 -1.5 1
GSM1061138 1 3 1 minor 3 41 ductal NA 16 1 0 0.6 1
GSM1061137 0 3 6 perfect health 3 48 ductal premenopausal 28 0 0 3.1 1
GSM1061136 1 3 6 perfect health 3 60 ductal postmenopausal 8 1 0 0.5 1
GSM1061135 0 1 6 perfect health 1 56 ductal NA 12 0 0 -0.6 1
GSM1061134 0 3 6 major problems 2 78 ductal postmenopausal 45 0 1 0.4 1
GSM1061133 1 1 6 perfect health 2 43 ductal premenopausal 12 0 0 -0.7 1
GSM1061132 1 3 6 perfect health 2 69 ductal NA 42 0 2 1.4 1
GSM106113 0 1 6 perfect health 2 53 ductal NA 18 0 0 -0.6 1
GSM1061130 1 1 6 perfect health 3 54 lobular postmenopausal 32 1 0 -0.7 1
GSM1061129 1 1 6 major problems 2 63 ductal NA 35 0 0 -1.1 1
GSM1061128 0 3 6 perfect health 3 38 ductal premenopausal 17 0 0 2.4 0
GSM1061127 1 3 6 major problems 3 70 ductal postmenopausal 45 0 1 1.6 1
GSM1061126 1 1 3 minor 2 53 lobular postmenopausal 8 0 0 -1.2 1
GSM1061125 1 equivocal 3 minor 2 62 ductal postmenopausal 15 0 0 -0.3 1
GSM1061124 1 equivocal 3 minor 2 58 ductal postmenopausal 18 0 1 0.1 1
GSM1061123 1 1 3 minor 1 51 ductal postmenopausal 12 0 0 -1 1
GSM1061122 1 equivocal 1 minor 2 43 ductal premenopausal 13 0 0 -0.1 1
GSM106112 1 1 6 minor 1 56 lobular postmenopausal 20 0 0 -1 1
GSM1061120 0 3 6 perfect health 3 45 ductal premenopausal 13 0 1 1.2 1
GSM1061119 1 1 6 major problems 2 64 ductal postmenopausal 6 0 0 -1.9 1
GSM1061118 0 3 6 major problems 3 87 ductal postmenopausal 45 1 0 1.9 0
GSM1061117 1 1 6 minor 2 51 ductal NA 13 0 1 -0.4 1
GSM1061116 1 1 6 minor 2 67 lobular postmenopausal 30 0 0 -2.3 1
GSM1061115 1 1 6 average for age 1 84 ductal postmenopausal 13 0 0 -0.8 1
GSM1061114 0 3 9 perfect health 2 56 ductal postmenopausal 9 0 0 0.8 0
GSM1061113 0 3 9 perfect health 3 47 ductal premenopausal 33 0 0 3.3 0
GSM1061112 1 1 9 perfect health 1 78 ductal postmenopausal 17 0 0 -0.5 1
GSM106 0 3 6 NA 3 76 ductal postmenopausal 30 1 2 1.6 0
GSM1061110 1 equivocal 6 major problems 2 53 ductal NA 15 0 0 -0.1 1
GSM1061109 1 1 6 major problems 1 52 lobular premenopausal 12 0 0 -2.3 1
GSM1061108 1 1 6 minor 2 47 ductal NA 16 0 0 -1.5 1
GSM1061107 1 3 6 major problems 1 49 ductal premenopausal 15 0 0 1 1
GSM1061106 1 3 6 perfect health 2 58 ductal NA 15 NA 0 0.7 1
GSM1061105 1 3 6 minor 3 77 ductal postmenopausal 22 0 3 1.3 1
GSM1061104 0 equivocal 6 minor 2 60 ductal postmenopausal 9 0 0 0.1 1
GSM1061103 0 3 6 average for age 2 75 ductal postmenopausal 25 0 2 0.9 1
GSM1061102 1 3 6 minor 3 63 ductal NA 18 1 1 0.8 1
GSM106110 1 1 6 perfect health 2 66 ductal postmenopausal 15 0 0 -0.6 1
GSM1061100 0 3 6 perfect health 3 49 ductal premenopausal 15 1 2 0.8 0
GSM1061099 1 3 9 perfect health 2 47 ductal premenopausal 20 0 0 0.4 1
GSM1061098 1 3 9 perfect health 2 55 ductal postmenopausal 17 0 0 2 1
GSM1061097 0 3 9 perfect health 2 44 ductal premenopausal 26 0 0 0.7 1
GSM1061096 1 1 9 perfect health 2 64 ductal postmenopausal 13 0 0 -1 1
GSM1061095 0 3 9 perfect health 2 64 ductal postmenopausal 32 0 1 0.4 1
GSM1061094 1 1 9 perfect health 1 49 ductal premenopausal 21 0 0 -0.6 1
GSM1061093 1 1 9 perfect health 2 44 ductal premenopausal 15 0 0 -0.6 1
GSM1061092 1 3 9 perfect health 2 44 ductal premenopausal 25 0 0 1.1 1
GSM106109 1 1 9 perfect health 2 42 lobular premenopausal 17 0 0 -1.2 1
GSM1061090 0 3 9 perfect health 3 31 ductal premenopausal 23 0 0 2.8 0
GSM1061089 1 equivocal 9 perfect health 2 53 ductal premenopausal 19 0 0 -0.1 1
GSM1061088 0 1 9 average for age 3 82 lobular postmenopausal 27 0 0 -0.3 0
GSM1061087 1 1 9 perfect health 1 64 ductal postmenopausal 12 0 0 -0.8 1
GSM1061086 1 1 9 perfect health 2 61 ductal postmenopausal 15 0 0 -0.4 1
GSM1061085 0 3 9 perfect health 3 73 lobular postmenopausal 22 0 0 0.4 1
GSM1061084 0 3 9 average for age 3 82 ductal postmenopausal 22 1 0 0.4 0
GSM1061083 1 1 9 perfect health 2 65 ductal postmenopausal 11 0 1 -2.2 1
GSM1061082 0 3 9 perfect health 3 35 ductal premenopausal 22 0 1 2.9 1
GSM106108 1 equivocal 2 perfect health 2 61 ductal postmenopausal 25 0 1 -0.1 1
GSM1061080 1 1 2 minor 1 48 ductal premenopausal 10 0 0 -2.5 1
GSM1061079 1 equivocal 2 minor 2 58 ductal postmenopausal 30 0 1 0.2 1
GSM1061078 1 equivocal 2 minor 2 47 ductal premenopausal 17 0 0 -0.1 1
GSM1061077 1 equivocal 1 minor 3 71 ductal postmenopausal 42 0 0 0.1 1
GSM1061076 0 equivocal 1 average for age 2 71 ductal postmenopausal 12 0 0 -0.1 0
GSM1061075 1 3 1 average for age 3 78 ductal postmenopausal 42 1 0 0.6 1
GSM1061074 1 equivocal 1 minor 2 49 ductal premenopausal 15 0 0 -0.2 1
GSM1061073 1 3 1 average for age 3 55 ductal postmenopausal 12 0 0 1.3 1
GSM1061072 1 3 1 average for age 3 73 ductal postmenopausal 40 0 3 1.5 1
GSM106107 1 1 1 perfect health 1 42 ductal premenopausal 41 0 0 -0.8 1
GSM1061070 1 equivocal 1 major problems 1 81 ductal postmenopausal 14 0 0 -0.2 1
GSM1061069 1 equivocal 6 minor 3 42 ductal premenopausal 17 0 0 0.2 1
GSM1061068 1 equivocal 6 average for age 1 78 lobular postmenopausal 19 0 0 -0.3 1
GSM1061067 1 3 6 perfect health 3 53 ductal premenopausal 21 0 1 0.4 1
GSM1061066 0 1 9 perfect health 2 50 ductal postmenopausal 15 1 0 -0.3 1
GSM1061065 0 3 9 perfect health 2 39 ductal premenopausal 13 0 0 2.4 0
GSM1061064 1 equivocal 9 perfect health 2 53 lobular postmenopausal 28 0 3 -0.2 1
GSM1061063 1 3 9 perfect health 3 41 ductal premenopausal 28 0 1 1.5 1
GSM1061062 0 3 9 perfect health 3 46 ductal premenopausal 32 0 0 3.1 0
GSM106106 0 1 3 minor 1 66 ductal postmenopausal 9 0 0 -2 1
GSM1061060 0 3 3 major problems 3 69 ductal postmenopausal 21 0 0 3.1 0
GSM1061059 1 3 3 major problems 2 60 ductal postmenopausal 24 0 0 0.6 1
GSM1061058 1 3 3 minor 3 54 lobular postmenopausal 35 0 0 0.9 1
GSM1061057 1 3 3 NA 3 71 ductal postmenopausal 19 0 0 1.5 1
GSM1061056 1 equivocal 3 average for age 1 76 ductal postmenopausal 24 0 0 -0.2 1
GSM1061055 1 equivocal 3 perfect health 1 78 ductal postmenopausal 18 0 0 -0.3 1
GSM1061054 1 1 8 perfect health 3 73 ductal postmenopausal 44 0 3 -0.6 1
GSM1061053 0 3 2 minor 3 48 ductal premenopausal 11 0 0 1.2 0
GSM1061052 1 equivocal 2 minor 2 56 ductal postmenopausal 16 1 2 0.3 1
GSM106105 1 1 2 minor 2 77 ductal postmenopausal 11 0 1 -1 1
GSM1061050 1 1 2 minor 2 51 ductal premenopausal 28 0 1 -1.5 1
GSM1061049 1 1 2 minor 1 67 ductal postmenopausal 18 0 0 -2.3 1
GSM1061048 1 equivocal 2 perfect health 2 48 ductal premenopausal 10 0 0 0 1
GSM1061047 1 1 6 perfect health 3 67 ductal postmenopausal 18 0 1 -0.4 1
GSM1061046 0 3 6 perfect health 2 66 ductal postmenopausal 50 0 0 0.7 1
GSM1061045 1 1 6 minor 1 72 ductal postmenopausal 11 0 3 -1.8 1
GSM1061044 1 1 6 perfect health 2 53 ductal NA 12 0 0 -1.3 1
GSM1061043 0 3 6 minor 3 54 ductal postmenopausal 45 1 0 1.5 0
GSM1061042 0 3 6 perfect health 2 61 ductal postmenopausal 10 0 0 0.6 1
GSM106104 1 equivocal 1 major problems 2 81 lobular postmenopausal 15 0 0 0.1 1
GSM1061040 1 equivocal 1 minor 2 47 ductal premenopausal 13 0 0 0 1
GSM1061039 0 3 1 NA 3 90 ductal postmenopausal 18 NA 0 0.4 0
GSM1061038 1 1 1 minor 2 61 lobular postmenopausal 11 0 0 -0.8 1
GSM1061037 1 1 1 average for age 1 76 lobular postmenopausal 16 0 0 -2.2 1
GSM1061036 0 3 1 perfect health 3 43 ductal NA 19 0 0 2.5 0
GSM1061035 1 1 1 average for age 2 65 ductal postmenopausal 30 0 0 -0.6 1
GSM1061034 0 3 4 average for age 2 59 ductal postmenopausal 10 1 0 0.5 0
GSM1061033 1 3 4 major problems 2 60 ductal postmenopausal 22 0 0 2.2 1
GSM1061032 1 3 6 perfect health 2 68 ductal postmenopausal 17 0 0 0.7 1

Tags

  • breast
  • breast cancer
  • breast carcinoma
  • cancer
  • carcinoma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use